Abstract:Importance: Repeated transfusions in preterm neonates with anemia of prematurity replace fetal hemoglobin (HbF) with adult Hb (HbA), which has a low oxygen affinity. The reduction of HbF is associated with a higher incidence of retinopathy of prematurity (ROP). Objective: To assess whether HbF and HbA are differently associated with cerebral tissue oxygenation in preterm neonates. Design, setting, and participants: This cohort study was a single-center, pilot study on cerebral oxygenation kinetics in preterm neonates with a gestational age between 24.0 weeks and 27.9 weeks who were admitted to the neonatal intensive care unit of Policlinico Universitario A. Gemelli IRCCS from December 27, 2021, to May 15, 2023. This study was ancillary to the ongoing, double-blind, multicenter Umbilical or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity (BORN) randomized clinical trial. The BORN trial outcome was ROP severity in neonates randomized to receive standard packed red blood cell (PRBC) transfusions obtained from RBCs of adult donors (A-RBCs) or from cord blood (CB-RBCs). According to standard procedures at the institute's neonatal intensive care unit, patients concurrently received continuous cerebral near-infrared spectroscopy (NIRS) monitoring. This cohort study was not prespecified in the trial protocol. Exposure: Transfusion with A-RBCs or CB-RBCs. Main outcomes and measures: The main outcome was the kinetics of cerebral regional oxygen saturation (crSO2) and cerebral fraction of tissue oxygen extraction (cFTOE) associated with A-RBC or CB-RBC transfusions. Cerebral NIRS monitoring was performed by neonatologists and nurses, who were blinded to the PRBC type. The NIRS monitoring was conducted starting with the blood product order, during transfusion, and for the subsequent 24 hours after transfusion completion. The mean treatment effects of A-RBCs or CB-RBCs were quantified using a linear mixed model for repeated measures. Results: Of 23 randomized neonates, 17 (11 male [64.7%]; median gestational age at birth, 25.6 weeks [IQR, 25.3-26.1 weeks]) with a median birth weight of 840 g (IQR, 580-900 g) were included in the study; NIRS was evaluated for 42 transfusion episodes, of which 22 were A-RBCs and 20 were CB-RBCs. Globally considering all posttransfusion time points, the overall crSO2 covariate-adjusted mean after CB-RBC transfusions was 5.27% lower (95% CI, 1.20%-9.34%; P = .01) than that after A-RBC transfusions, while the cFTOE after CB-RBC transfusions was 6.18% higher (95% CI, 1.66%-10.69%; P = .009) than that after A-RBCs. Conclusions and relevance: The findings of this cohort study suggest that A-RBC transfusions may be associated with more oxygen delivery to cerebral tissues of preterm neonates than transfusions from CB-RBCs. This finding may explain the previously observed association between low HbF and high ROP risk. It also suggests that use of CB to meet the RBC transfusion needs of neonates with a gestational age of less than 28 weeks may protect cerebral tissues from overexposure to oxygen.

Optimizing haemoglobin measurements in VLBW newborns: Insights from a comparative retrospective study

[Comparison of Clinical Outcomes in Very Low Birth Weight Infants with Anemia by Different Transfusion Strategies].

Capillary blood parameters are gestational age, birthweight, delivery mode and gender dependent in healthy preterm and term infants

Validity of non-invasive point-of-care hemoglobin estimation in healthy and sick children—a method comparison study

Accuracy and Reliability of Whole Blood Bilirubin Measurements Using a Roche Blood Gas Analyzer for Neonatal Hyperbilirubinemia Screening and Risk Stratification

Coagulation assay results at birth in preterm infants: A cohort study highlighting the relevance of local reference values for interpretation

Accuracy of Pulse Oximetry in the Presence of Fetal Hemoglobin—A Systematic Review

Estimation of gestational age-specific reference intervals for coagulation assays in a neonatal intensive care unit using real-world data

Accuracy of point-of-care testing devices for haemoglobin in the operating room: meta-analysis

Noninvasive monitoring of red blood cell transfusion in very low birthweight infants using diffuse optical spectroscopy

Evaluation of the Impact of Diagnostic Blood Loss and Red Blood Cell Transfusion in Very-Low-birth-weight Anaemic Neonates During Hospitalization: A Multi-Centre Retrospective Clinical Study

Estimation of the reference values and decision limits for growth hormone in newborns using dried blood spots

A Method for Compensating Hemoglobin Interference in Total Serum Bilirubin Measurement Using a Simple Two-Wavelength Reflectance Photometer

Differences in Cerebral Tissue Oxygenation in Preterm Neonates Receiving Adult or Cord Blood Red Blood Cell Transfusions

Coagulation profiles and percentiles in neonates with hypoxic‐ischemic encephalopathy undergoing therapeutic hypothermia: A step toward more accurate transfusion thresholds

Viscoelastic coagulation testing in Neonatal Intensive Care Units: advantages and pitfalls in clinical practice

Red Blood Cell Transfusion in European Neonatal Intensive Care Units

Umbilical Cord Blood as an Alternative to Neonatal Blood for Complete Blood Count: A Comparison Study

Cord blood transfusions in extremely low gestational age neonates to reduce severe retinopathy of prematurity: results of a prespecified interim analysis of the randomized BORN trial

Inter-observer variability of right ventricular output measurement in newborn infants: an observational study

Fetal haemoglobin and oxygen requirement in preterm infants: an observational study